About Us

Equithrive is the “Pioneer in Equine Resveratrol Therapy.” The company has an ongoing focus on research, development and sales of products that support equine joint health and equine metabolic function. Equithrive is the sister company of Petthrive, which manufactures resveratrol products to support mobility and joint health in aging dogs.


In 2007, Dr. Patrick Lawless was working as a biopharmaceutical research scientist developing new anti-inflammatory drugs when he witnessed Kentucky Derby winner Barbaro’s tragic breakdown in the Preakness Stakes. With the entire nation, he followed the courageous battle waged by this horse and his caretakers until he finally succumbed to the tragedy of laminitis.

Through his own research, Dr. Lawless had become familiar with the natural anti-inflammatory compound resveratrol. Resveratrol was receiving a great deal of recognition at that time due to it being the first compound identified to activate the “anti-aging gene” SIRT1. Pat realized that there was an opportunity to use resveratrol to improve horse health and performance.

In 2008, Dr. Lawless founded the company Equithrive and introduced the first equine product (Equithrive® Joint) to contain a purified form of resveratrol. Since then, the efficacy of Equithrive Joint in supporting soundness and a healthy inflammatory response in horses has been proven in multiple university studies. The company has also launched a higher dose resveratrol product (Metabarol®) that has been demonstrated to support healthy insulin levels and metabolic function in horses. To learn more about the research that has been conducted on our products, see our Proof Page.




Subscribe to our newsletter

(* indicates required)